Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas.
暂无分享,去创建一个
P. Sorensen | S. Aparicio | S. McKinney | T. Triche | D. Wai | H. Jürgens | M. Pollak | M. Gottardis | D. Saunders | J. Carboni | J. Potratz | T. Ng | Tony L. Ng